Nucleus RadioPharma

What you need to know about #radiopharma in 2025: Hear from Geoff Johnson, MD, PhD on December 11th, 2024 at 10AM ET during our live event, Greatest Hits in RLT: A Year in Review and Prognostications for 2025. Dr. Johnson will be discussing advancements in radioligand therapies, predictions for 2025, and more! You won't want to miss it. Register now! https://hubs.ly/Q02Zd-Qh0 #Radiopharmaceuticals #Biotech #Oncology

What makes quality control in radiopharmaceuticals uniquely challenging? From managing isotope variability to meeting both FDA and NRC standards, each phase requires meticulous precision and innovation. This article dives into the cutting-edge advances—like rapid endotoxin testing and AI-driven safety protocols—that are transforming QC in radiopharma. #Radiopharmaceuticals #QualityControl #FDA #Innovation

Welcome to the world of #radiopharma quality control, where the unique nature of radioactive treatments and stringent FDA and NRC standards present unique challenges. In our latest article written by our VP of Quality, Wayne Alexander, we dive into some critical challenges, from sterility testing, rapid bacterial endotoxins testing, and releasing under quarantine to managing the variability in raw materials. Read more: https://hubs.ly/Q02YMNw60 #Radiopharmaceuticals #QualityControl #FDA

The Nucleus RadioPharma team proudly logged 2,190.9 total miles and finished in 3rd place!??Huge thanks to the Oncidium foundation for launching the initiative and driving awareness around #radiotheranostics. Each mile brings us closer to a future where these treatments are within reach for all who need them. #Radiopharmaceuticals #CancerCare #RLT https://hubs.ly/Q02YB5xk0

We are excited to announce that Nucleus RadioPharma has entered into a collaboration with Clarity Pharmaceuticals! This partnership will leverage our state-of-the-art manufacturing capabilities to produce Clarity’s Cu-67 SAR-bisPSMA drug product. Together, we aim to enhance the treatment landscape for prostate cancer, ensuring timely and reliable access to innovative radiopharmaceutical therapies. Stay tuned for more updates as we embark on this promising journey. #Radiopharmaceuticals #CancerTreatment #Innovation https://lnkd.in/ez_NdZW8

A promising clinical trial at University College London Hospitals used targeted radioactive therapy to shrink aggressive glioblastoma tumors—one patient’s tumor was reduced by half. Stories like these fuel our excitement and commitment to help accelerate U.S. clinical trials and bring life-changing treatments closer to patients with limited options. #Radiopharmaceuticals #CancerCare #ClinicalTrials https://hubs.ly/Q02Xp_CC0

Thank you to Fierce Pharma for covering our recent expansion news. Our new facilities strengthen our commitment to advancing radiopharmaceutical access, enhancing production capabilities, and accelerating clinical trials. The future is bright! https://hubs.ly/Q02X1pHy0 #Radiopharmaceuticals #CancerCare #CDMO

How fast can your organization make decisions? In the field of #radiopharma, every second counts. Learn more about four key considerations #biotech and #pharma companies should make before manufacturing radiotherapies in our recent blog post written by Chief Commercial Officer, Kathy Spencer-Pike. https://hubs.ly/Q02WxFpw0 #Radiopharmaceuticals #CDMO #NuclearMedicine

The Nucleus RadioPharma team is on the move and has tackled over 965 miles for the 3rd Edition Tackle Cancer Challenge with the Oncidium foundation! ??♂? Do you want to join the movement to raise awareness for #radiotheranostics and funds that will be allocated exclusively to cancer patient projects? It is not too late to register! Sign up before the Challenge ends on November 10th: https://hubs.ly/Q02Wc-DV0 #Radiopharmaceuticals #CancerCare #RLT

When our two new facilities in Mesa, Arizona and Springhouse, Pennsylvania are operational, they’ll help us supply partners in Asia and Europe. Additionally, they will help us reduce the supply chain time for life-saving #radiopharmaceuticals by up to 30%. Special thanks to Anna Brown of Endpoints News for getting the word out on this exciting news. Hiring for the facilities will begin in late 2025. Stay tuned for updates! https://hubs.ly/Q02VKf7G0 #NuclearMedicine #CDMO #RLT